Image background
Image background
Image background
  • About Sanoculis
     
    Sanoculis Ltd. is a medical device start-up company which develops an innovative surgical procedure for the treatment of the Glaucoma. This procedure is safe, effective and simple to perform and intends to supplement currently available surgical solutions in a multi-billion international market. Sanoculis was established in 2012 and is backed by private and institutional investors.


     

     
         
    MIMS® Procedure
     
    Minimally Invasive Micro Sclerostomy (MIMS®) is a surgical procedure which consists of a single patient use sterile tool and a multi-use external machine. In the course of the surgery, a sclerocorneal drainage channel is created in order to reduce intraocular pressure (IOP), one which is comparable to existing surgical techniques. The channel created with the MIMS® is designed to obtain a long-lasting controlled fluid flow along with minor related complications. The procedure is minimally invasive, and apparently simpler and faster than existing methods.